Aurobindo Pharma Ltd share price logo

Aurobindo Pharma Ltd

NSE: AUROPHARMA

BSE: 524804

Mid Cap

Healthcare Sector

Pharma Sector

₹1647.70

-12.30

(-0.74%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

🔔 Regulatory Approval Alert

Aurobindo Pharma's subsidiary Apitoria Pharma's Telangana API facility cleared US FDA inspection with one procedural observation; company received US FDA approval for inhaler product.

What are INDmoney investors doing with Aurobindo Pharma shares?

Based on platform-user behaviour - not analyst opinion or company fundamentals.

Search interest on INDmoney

-24%

Searches for Aurobindo Pharma on INDmoney have decreased by 24% over the last 30 days.

Investment activity on INDmoney

-22.25%

Investment activity in Aurobindo Pharma among INDmoney users has decreased by 22.25% over the last 30 days.

Among the most traded stocks

261st

Aurobindo Pharma was the 261st most traded stock on INDmoney over the last 7 days.

Average holding period of indmoney investors

30 days

INDmoney investors hold Aurobindo Pharma shares for an average of 30 days.

Key Events for Aurobindo Pharma

Last Dividend Declared

₹4.00 per share, declared on 04/08/2025

View Dividend History

Aurobindo Pharma Stock Performance

as on September 16, 2026 at 6:38 pm IST

  • Day's Low

    Day's High

    ₹1,623.00
    ₹1,657.10
    downward going graph

    1.50%

    Downside

    0.57%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹1,061.30
    ₹1,717.00
    downward going graph

    35.59%

    Downside

    4.21%

    Upside

    downward going graph

Aurobindo Pharma share price movements today

Previous Close
₹1,660.00
Open
₹1,647.00
Volume
3.54L
Upper Circuit
₹1,826.00
Lower Circuit
₹1,494.00
Day's Low - High
₹1,623.00 - ₹1,657.10
52 Week Low - High
₹1,061.30 - ₹1,717.00

Aurobindo Pharma Historical Returns

1 Month Return
+ 2.02 %
3 Month Return
+ 18.85 %
1 Year Return
+ 52.07 %
3 Year Return
+ 85.56 %
5 Year Return
+ 119.94 %

Aurobindo Pharma Fundamentals

as on September 16, 2026 at 1:08 pm IST

Market Cap

₹95,512.73 Cr

Return on Equity (ROE)

11.17

PE Ratio (TTM)

26.25

Return on capital employed (ROCE)

12.91

Industry PE ratio

51.81

Beta (LTM)

0.35

P/B Ratio

3.33

Dividend Yield

0.31

PEG Ratio

4.62

Quarterly Earnings Growth YOY

25.22

EPS (TTM)

60.31

Book Value

652.39

Aurobindo Pharma Stock Valuation

as on September 16, 2026 at 1:08 pm IST

Aurobindo Pharma in the last 5 years

  • Overview

  • Trends

Lowest (6.73x)

March 23, 2020

Today (26.25x)

September 11, 2026

Industry (51.81x)

September 11, 2026

Highest (27.59x)

December 21, 2023

LowHigh

Today’s Price to Earnings Ratio: 26.25x

Aurobindo Pharma Technical Analysis

Track how Aurobindo Pharma technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bullish

Moving Averages

Bearish

Neutral

Bullish

Bullish

Oscillators

Bearish

Neutral

Bullish

Neutral

Overall

Bearish2
Bullish11
Neutral2

Oscillators

Name

Value

Action

MACD level (12,26)
0.55
Bearish
CCI (20)
-203.51
Bullish
RSI (14)
59.02
Neutral
Momentum (10)
-0.2
Bearish
ADI (14)
24.38
Neutral
Ultimate Oscillator (7,14,28)
70.67
Bullish

Moving Averages

Name

Value

Action

SMA (20)
1646.19
Bullish
EMA (20)
1646.39
Bullish
VWMA (20)
1646.62
Bullish
SMA (50)
1645.57
Bullish
EMA (50)
1644.81
Bullish
SMA (200)
1638.9
Bullish
EMA (200)
1642.2
Bullish
KAMA (200)
1645.5
Bullish
DEMA (200)
1639.85
Bullish

Aurobindo Pharma Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Aurobindo Pharma with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Aurobindo Pharma Ltd image
Aurobindo Pharma Ltd
BUY95,512.7323.99%0.603,50233,653
Sanofi India Ltd image
Sanofi India Ltd
BUY7,210.69-12.22%0.004132,013
Zydus Lifesciences Ltd image
Zydus Lifesciences Ltd
BUY1,09,625.6718.94%0.695,02651,180
Abbott India Ltd image
Abbott India Ltd
BUY55,515.634.88%0.001,4146,445
Glaxosmithkline Pharmaceuticals Ltd image
Glaxosmithkline Pharmaceuticals Ltd
BUY47,753.8715.84%0.561,0353,821
See all

Market expectation of Aurobindo Pharma Stock

Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data

BUY

62.96%

Buy

18.52%

Hold

18.52%

Sell

Aurobindo Pharma Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sales
7,150.71
7,271.23
7,491.92
7,457.65
7,646.21
7,893.15
8,381.12
7,791.77
8,236.96
8,604.51
8,751.5
9,105.82
Other Income
187.88
162.52
135.62
220.93
136.3
158.88
134.81
107.22
122.25
188.01
117.04
264.23
Total Income
7,407.3
7,514.3
7,715.77
7,787.95
7,932.37
8,137.4
8,516.93
7,975.36
8,407.95
8,833.91
8,970.38
9,414.58
Expenses
5,845.98
5,753.06
6,042.11
5,948.84
6,229.93
6,400.54
6,622.39
6,265.11
6,607.6
6,937.89
7,102.99
7,311.01
Operating Profit
1,304.73
1,518.17
1,449.81
1,508.81
1,416.28
1,492.61
1,758.73
1,526.66
1,629.36
1,666.62
1,648.51
1,794.81
Operating Profit Margin %
18.25%
20.88%
19.35%
20.23%
18.52%
18.91%
20.98%
19.59%
19.78%
19.37%
18.84%
19.71%
Profit Before Interest, Tax and Depreciation
1,561.32
1,761.24
1,673.66
1,839.11
1,702.44
1,736.86
1,894.54
1,710.25
1,800.35
1,896.02
1,867.39
2,103.57
Interest
68.18
75.55
89.43
111.04
112.7
118.48
115.02
97.75
95.24
92.77
98.21
101.66
Depreciation
417.5
423.27
354.33
404.18
382.28
418.53
444.43
405.7
429.19
464.73
478.57
486.82
Profit Before Tax
1,075.64
1,262.42
1,229.9
1,323.89
1,207.46
1,199.85
1,335.09
1,206.8
1,275.92
1,338.52
1,290.61
1,515.09
Tax Paid
323.7
322.45
322.55
405.67
390.51
354.28
432.26
382.6
427.79
428.72
369.77
483.06
Profit After Tax
751.94
939.97
907.35
918.22
816.95
845.57
902.83
824.2
848.13
909.8
920.84
1,032.03
Total Net profit including share of profit / Loss from associate company
751.94
939.97
907.35
918.22
816.95
845.57
902.83
824.2
848.13
909.8
920.84
1,032.03
EPS
12.83
16.04
15.51
15.69
14
14.56
15.56
14.2
14.61
15.67
15.86
17.86
Actual EPS
12.83
16.04
15.51
15.69
14
14.56
15.56
14.2
14.61
15.67
15.86
17.86
Adjusted EPS
12.83
16.04
15.51
15.69
14
14.56
15.56
14.2
14.61
15.67
15.86
17.86
Diluted EPS
12.83
16.04
15.51
15.69
14
14.56
15.56
14.2
14.61
15.67
15.86
17.86

Aurobindo Pharma Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
16,232.87
19,225.92
22,737.95
24,557.95
23,366.55
24,617.13
28,704.5
31,378.13
33,384.74
Other Income
105.12
118.36
86.2
3,195.42
320.35
290.59
557.38
621.85
493.61
Total Income
16,604.96
19,681.91
23,184.7
27,970.05
23,775.84
25,145.97
29,559.25
32,345.58
34,146.69
Expenses
12,728.08
15,759.95
18,315.2
19,496.58
19,227.94
21,148.41
23,367.89
25,172.63
26,872.68
Operating Profit
3,504.79
3,465.97
4,422.75
5,061.37
4,138.61
3,468.72
5,336.61
6,205.5
6,512.06
Operating Profit Margin %
21.59%
18.03%
19.45%
20.61%
17.71%
14.09%
18.59%
19.78%
19.51%
Profit Before Interest, Tax and Depreciation
3,876.88
3,921.96
4,869.5
8,473.47
4,547.9
3,997.56
6,191.36
7,172.95
7,274.01
Interest
77.71
162.66
159.77
74.49
48.64
140.48
289.71
457.24
383.97
Depreciation
557.97
667.95
966.71
1,055.38
1,126.52
1,244.58
1,521.66
1,649.42
1,778.19
Profit Before Tax
3,241.2
3,091.35
3,743.02
7,343.6
3,372.74
2,612.5
4,379.99
5,066.29
5,111.85
Tax Paid
818.28
726.85
913.51
2,009.77
725.63
684.85
1,211.02
1,582.72
1,608.88
Profit After Tax
2,422.92
2,364.5
2,829.51
5,333.83
2,647.11
1,927.65
3,168.97
3,483.57
3,502.97
Total Net profit including share of profit / Loss from associate company
2,422.92
2,364.5
2,829.51
5,333.83
2,647.11
1,927.65
3,168.97
3,483.57
3,502.97
EPS
41.36
40.36
48.32
91.04
45.19
32.9
54.16
59.81
60.34
Actual EPS
41.36
40.36
48.32
91.04
45.19
32.9
54.16
59.81
60.34
Adjusted EPS
41.36
40.36
48.32
91.04
45.19
32.9
54.16
59.81
60.34
Diluted EPS
41.36
40.36
48.32
91.04
45.19
32.9
54.16
59.81
60.34

Aurobindo Pharma Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Net Cash from Operating Activities
1,419.76
3,278.58
1,954.52
1,650.97
4,381.28
3,329.05
5,016.48
2,386.75
2,434.52
3,924.62
5,526.37
Cash Flow from Investing Activities
-1,445.51
-1,787.18
-1,926.76
-2,904.39
-1,562.86
596.57
-3,211.36
-3,971.4
-4,241.78
-1,866.04
-2,629.61
Cash Flow from Financing Activities
365.44
-1,915.26
864.15
1,919.06
-1,947.18
-1,364.94
-2,969.27
1,814.41
800.42
119.78
-1,269.15
Net Cash Flow
339.69
-423.86
891.91
665.64
871.24
2,560.68
-1,164.15
229.76
-1,006.84
2,178.36
1,627.61

Aurobindo Pharma Stock Shareholding Pattern

Numbers in percentages

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Promoters
51.83%
51.83%
51.8%
51.82%
51.82%
51.82%
51.82%
51.82%
51.82%
51.82%
51.88%
DII
20.23%
23.28%
24.77%
25.13%
25.2%
26.23%
26.93%
27.6%
27.68%
25.87%
25.1%
FII
0%
18.02%
16.73%
16.59%
16.29%
15.33%
14.37%
14.21%
13.94%
15.24%
16.38%
Public
6.85%
6.87%
6.7%
6.46%
6.69%
6.61%
6.87%
6.38%
6.55%
7.08%
6.64%
Total Outstanding Shares
58,59,38,609
58,59,38,609
58,59,38,609
58,08,01,623
58,08,01,623
58,08,01,623
58,08,01,623
58,08,01,623
58,08,01,623
58,08,01,623
57,53,77,895
Total Shareholders
2,41,944
2,44,575
2,38,622
2,48,488
2,57,962
2,69,323
2,72,208
2,47,662
2,36,859
2,41,298
2,39,073

Mutual Funds Buying / Exiting Aurobindo Pharma

Holdings as of 15 Sep 2026 · based on the latest SEBI-mandated portfolio disclosures

Mutual Funds Buying Aurobindo Pharma

Sorted by largest increase in holding, month-over-month.

No buying activity data available right now

No buying activity data available right now

Mutual Funds Exiting Aurobindo Pharma

Sorted by largest decrease in holding, month-over-month.

Fund Name

Value of Holding

Decrease (MoM)

Holding %

SBI Large & Midcap Fund Direct Growth

SBI Large & Midcap Fund Direct Growth

₹774.42 Cr

₹103.76 Cr (-11.82%)

1.91%

Quant Mid Cap Fund Growth Option Direct Plan

Quant Mid Cap Fund Growth Option Direct Plan

₹840.89 Cr

₹41.75 Cr (-4.73%)

9.95%

Aurobindo Pharma Corporate Actions

View detailed summary of the earnings and dividend history of Aurobindo Pharma.

  • Aurobindo Pharma Ltd Earnings Results

    Aurobindo Pharma Ltd’s net profit jumped 25.2% since last year same period to ₹1,032.56Cr in the Q1 2026-2027. On a quarterly growth basis, Aurobindo Pharma Ltd has generated 12.08% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Aurobindo Pharma Ltd Dividends August,2025

    In the quarter ending June 2025, Aurobindo Pharma Ltd has declared dividend of ₹4.00 per share on 04 Aug 2025 - translating a dividend yield of 0.24%.

    Read More about Dividends

Indices Featuring Aurobindo Pharma Stock

Check stock indices that include Aurobindo Pharma.

S&P BSE 150 MidCap

₹16,525.68

+31.98 (▲0.19%)

Nifty 200

₹13,516.35

+74.10 (▲0.55%)

Nifty Midcap Sel

₹14,316.65

+50.30 (▲0.35%)

S&P BSE 400 MidSmallCap

₹12,420.95

+14.11 (▲0.11%)

BSE Healthcare

₹50,358.12

-120.69 (▲0.24%)

S&P BSE 250 LargeMidCap

₹10,422.19

+51.67 (▲0.50%)

Nifty LargeMidcap 250

₹16,156.10

+68.65 (▲0.43%)

BSE 200

₹10,927.60

+57.59 (▲0.53%)

Nifty 500

₹22,583.40

+105.95 (▲0.47%)

Nifty Healthcare

₹16,256.60

-42.40 (▲0.26%)

Nifty Midcap 150

₹22,408.40

+49.60 (▲0.22%)

Nifty Midcap 50

₹17,592.70

+36.35 (▲0.21%)

NIFTY PHARMA

₹26,110.95

-77.45 (▲0.30%)

S&P BSE MidCap Select

₹18,288.58

+30.06 (▲0.16%)

Nifty Midcap 100

₹61,010.35

+132.10 (▲0.22%)

Nifty MidSmallcap 400

₹20,776.80

+26.10 (▲0.13%)

BSE 500

₹35,324.18

+154.56 (▲0.44%)

Insights on Aurobindo Pharma Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 5 quarters, 824.75 Cr → 1.03K Cr (in ₹), with an average increase of 5.4% per quarter

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 15.24% to 16.38% in Jun 2026 quarter

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, AUROPHARMA has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 5 quarters, 7.97K Cr → 9.41K Cr (in ₹), with an average increase of 4.1% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, AUROPHARMA stock has moved up by 18.9%

  • imgPOSITIVE IMPACT

    Promoter Holding Up

    img

    Promoters have increased holdings from 51.82% to 51.88% in Jun 2026 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 157.4% return, outperforming this stock by 71.8%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 7.08% to 6.64% in Jun 2026 quarter

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 17.79% to 16.71% in Jun 2026 quarter

Aurobindo Pharma Stock Futures & Options Contracts

View the latest movement in Aurobindo Pharma Futures & Options, including strike prices, expiry dates, and percentage changes.

Aurobindo Pharma Options

Name
Expiry
Strike Price
LTP
Absolute Change
Change
AUROPHARMA 29 Sep ₹1680 Call
September 29, 2026
₹1680
₹21.75
-0.5
-2.25%
AUROPHARMA 29 Sep ₹1700 Call
September 29, 2026
₹1700
₹15.7
-0.8
-4.85%
AUROPHARMA 29 Sep ₹1660 Call
September 29, 2026
₹1660
₹29
-0.55
-1.86%
AUROPHARMA 29 Sep ₹1640 Call
September 29, 2026
₹1640
₹39.05
0.1
0.26%

Aurobindo Pharma Futures

Name
Expiry
Strike Price
LTP
Absolute Change
Change
AUROPHARMA 29 Sep Fut
September 29, 2026
-
₹1653.5
3.3
0.2%
AUROPHARMA 27 Oct Fut
October 27, 2026
-
₹1660.4
1.49
0.09%
AUROPHARMA 23 Nov Fut
November 23, 2026
-
₹1656
-6.98
-0.42%

About Aurobindo Pharma Ltd

Aurobindo Pharma Ltd is an Indian multinational pharmaceutical company incorporated in 1986. Aurobindo Pharma operates in several lines of business including APIs, generics, biosimilars, advanced drugs, and consumer healthcare.

The company is well known for its top products such as antibiotics, anti-malarials, cardiovascular, and anti-diabetic drugs. Its popular brands include Aurolife, Aurocare, Aurochem, and Aurovit. Aurobindo Pharma is one of the largest manufacturers of generic drugs in India, with a presence in over 150 countries worldwide.

Revenue: ₹9,105.82Cr as on June 2026 (Q1 FY27)
Net Profit: ₹1,032.03Cr as on June 2026 (Q1 FY27)
Listing date: 19 Oct, 1995
Chairperson Name: K Ragunathan
OrganisationAurobindo Pharma Ltd
HeadquartersHyderabad
IndustryPharmaceuticals
CEOK Ragunathan
E-voting on sharesClick here to vote

FAQs

What is Aurobindo Pharma share price today?

Aurobindo Pharma share price today stands at ₹1647.7 as on . Aurobindo Pharma share today touched a day high of ₹1657.1 and a low of ₹1623.

What is the 52 week high and 52 week low range for Aurobindo Pharma share?

Aurobindo Pharma touched a 52 week high of ₹1717 and a 52 week low of ₹1061.3. Aurobindo Pharma share price today i.e. is trending at ₹1647.7, which is -4.04% down from its 52 week high and 55.25% up from its 52 week low.

What is Aurobindo Pharma's market capitalisation today?

Aurobindo Pharma market capitalisation is ₹95,512.73 Cr as on .

How to buy Aurobindo Pharma shares?

To buy Aurobindo Pharma shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for AUROPHARMA or Aurobindo Pharma Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Aurobindo Pharma shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Aurobindo Pharma trading volume today?

Aurobindo Pharma trading volume is 3.54L as on . This means that 3.54L shares of Aurobindo Pharma were bought and sold on the stock market during today's trading session.

What are INDmoney investors doing with Aurobindo Pharma shares right now?

Based on aggregated, anonymised INDmoney platform data, search interest and investment activity in Aurobindo Pharma have both decreased over the past 30 days, and the average INDmoney investor holds the stock for 30 days. This reflects platform activity only and is not investment advice.